Effects of parabolic flight and spaceflight on the endocannabinoid system in humans by Strewe, Claudia et al.
 DOI 10.1515/revneuro-2012-0057   Rev. Neurosci. 2012; 23(5-6): 673–680
Research Article
 Claudia  Strewe ,  Matthias  Feuerecker ,  Igor  Nichiporuk ,  Ines  Kaufmann ,  Daniela  Hauer , 
 Boris  Morukov ,  Gustav  Schelling and  Alexander  Choukèr* 
 Effects of parabolic flight and spaceflight on the 
endocannabinoid system in humans 
 Abstract: The endocannabinoid system (ECS) plays an 
important role in the regulation of physiological functions, 
from stress and memory regulation to vegetative control 
and immunity. The ECS is considered a central and periph-
eral stress response system to emotional or physical chal-
lenges and acts through endocannabinoids (ECs), which 
bind to their receptors inducing subsequent effecting 
mechanisms. In our studies, the ECS responses have been 
assessed through blood concentrations of the ECs anand-
amide and 2-arachidonoylglycerol. In parallel, saliva corti-
sol was determined and the degree of perceived stress was 
quantified by questionnaires. This report summarizes the 
reactivity of the ECS in humans subjected to brief periods of 
kinetic stress and weightlessness during parabolic flights 
and to prolonged stress exposure during life onboard the 
International Space Station (ISS). Both conditions resulted 
in a significant increase in circulating ECs. Under the acute 
stress during parabolic flights, individuals who showed no 
evidence of motion sickness were in low-stress conditions 
and had a significant increase of plasma ECs. In contrast, 
highly stressed individuals with severe motion sickness 
had an absent EC response and a massive increase in hypo-
thalamic-pituitary-adrenal axis activity. Likewise, chronic 
but well-tolerated exposure to weightlessness and emo-
tional and environmental stressors on the ISS for 6 months 
resulted in a sustained increase in EC blood concentrations, 
which returned to baseline values after the cosmonauts ’ 
return. These preliminary results suggest that complex 
environmental stressors result in an increase of circulating 
ECs and that enhanced EC signaling is probably required 
for adaptation and tolerance under stressful conditions. 
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 Introduction 
 Spaceflight conditions reflect a complex environmental 
challenge with multiple aversive consequences for human 
health. In the light of manned orbital, lunar, and interplane-
tary mission, the assessment, monitoring, and maintenance 
of human health is a prerequisite for a successful mission 
accomplishment. Spaceflight, even when short in duration, 
can induce several adverse effects due to adaptation to the 
physical stressors of gravitational changes, radiation, mal-
nutrition, and psychological stress (Choukèr, 2012). These 
complex environmental challenges are most pronounced 
for extended periods during interplanetary missions 
(Choukèr, 2012). Although stressful conditions of psycholo-
gical or physical nature are known to activate multiple stress 
response systems (Selye, 1998), such as the hypothalamic-
pituitary-adrenal (HPA) axis, it remains to be determined 
to which degree the phylogenetically old and evolutionary 
well-preserved endocannabinoid system (ECS) responds to 
stress and to spaceflight conditions in particular. 
 The ECS consists of central and peripheral G-protein-
coupled receptors (CB1 and CB2; Pertwee et al., 2010) with 
their corresponding endogenous ligands, the endocannabi-
noids (ECs) anandamide and 2-arachidonoyl glycerol (2-AG; 
Pertwee, 2008). Other structurally related fatty acids, such 
as palmitoylethanolamide and oleoylethanolamide, are 
part of the same chemical group, the N-acylethanolamines, 
but bind as well to other receptors, such as the transient 
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receptor potential vanilloid type 1 receptor system or the 
G-protein-coupled receptor GPR55, and have potentiated 
effects (entourage effects) on anand amide (Ryberg et al., 
2007; Ho et al., 2008; Kallendrusch et al., 2012). 
 The ECs are known to play an important role in the 
modulation and regulation of various kinds of central and 
peripheral physiological responses to stress (Gorzalka 
et al., 2008). Neuroendocrine and neurochemical pro-
cesses with an influence on behavior, mood, and memory 
(Campolongo et al., 2009; Atsak et al., 2012) are affected 
as well as immune (Tanasescu and Constantinescu, 2010) 
or vegetative functions such as gastrointestinal motil-
ity or myocardial contractility (Weis et al., 2010b). Those 
processes and control functions are transmitted by signal-
ing pathways such as the HPA axis and the sympathetic 
nervous system. As they are stress modulated, the ECS 
influences their activity (Hill et al., 2010). 
 The acute stress response and its effects constitute an 
important survival reaction of the human body, whereas 
the chronic stress response or a persistent activation of 
the stress response system can lead to maladaptation syn-
dromes causing disorders characterized by a chronically 
increased allostatic load (McEwen, 2002), such as depres-
sion, chronic pain, posttraumatic stress disorder (Yehuda, 
2002), or autoimmune disease (McEwen and Dhabhar, 
2002). The question whether there is a positive or nega-
tive relationship between EC activity and the level of stress 
response is not yet understood (Di Marzo, 2008), and no 
data in humans subjected to stress in space are available. In 
this context, we performed two different studies addressing 
stressful conditions that are important during spaceflight, 
either during training or the mission to space, respectively. 
We asked (i) for the role of the peripheral ECS as a modu-
lator of stress and stress responses, (ii) if the changes in 
peripheral EC signaling are associated with HPA axis activ-
ity (e.g., the cortisol response), and (iii) to which degree 
acute or chronic environmental changes affect this system. 
 Acute vs. chronic stress 
 We tested the responsiveness of the ECS under two condi-
tions representing acute and chronic space-related stress 
exposures. Healthy subjects were investigated during 
spaceflight-associated conditions such as parabolic flights 
(http://www.novespace.com) as an acute stress model. 
 During the flights, the subjects are exposed to several 
abrupt changes due to gravitational acceleration/decel-
eration causing short violent kinetic stress on the human 
body. The brevity of the different acceleration phases pre-
vents any possible physiological adaptation mechanisms. 
Additionally, the hypergravity phases are interrupted by 
phases of microgravity evoking weightlessness. Those 
severe, fast-changing conditions heavily impact on the 
human sense of balance, leaving the subjects with only 
little control of their well-being and no possibility to 
escape the situation and therefore causing acute stress 
(Schneider et al., 2007, 2009; Chouker et al., 2010). 
 In contrast, long-duration space mission to the Inter-
national Space Station (ISS) offers a unique, complex 
model of chronic stress as a result of permanent micro-
gravity, high radiation doses, and confinement in a purely 
technical, hazardous, and potentially deadly condition. 
 EC and glucocorticoid measure-
ments and stress quantification 
 During both studies, we measured the concentrations of 
the ECs anandamide and 2-AG from venous blood samples. 
ECs were determined in whole blood collected into EDTA-
containing tubes (S-Monovette, Sarstedt, N ü mbrecht, 
Germany). During the parabolic flight campaign (PFC), 
the samples were immediately frozen in-flight on dry ice 
and stored at -80 ° C. The time delay between sampling and 
freezing was kept at a minimum, as previous experiments 
have shown that EC generation in native blood samples 
continues  ex vivo (Vogeser et al., 2006). On the ISS, blood 
vials were stored at -80 ° C until downloaded to Earth and 
analyzed ( Figure    5 ). The details of the high-performance 
liquid chromatography tandem mass spectrometry tech-
nique used for EC quantification are described elsewhere 
(Vogeser et al., 2006; Chouker et al., 2010). 
 Cortisol levels were analyzed from salivary samples 
taken in the morning before breakfast at approximately 
8:00 a.m. Saliva for cortisol measurements was collected by 
wetting a cotton swab for 60 – 90 s (Salivette, Sarstedt, N ü m-
brecht, Germany) and kept at room temperature (18 – 25 ° C). 
Free cortisol was quantified by an automated immunoas-
say system based on the principle of electrochemilumines-
cence (Elecsys Cortisol, Roche Diagnostics, Mannheim, 
Germany; Chouker et al., 2010). During the PFC, salivary 
and blood samples were taken at the time points T0 – T5 [in-
flight before the start of the parabolic maneuvers (T0); after 
10 (T1), 20 (T2), and 30 (T3) parabolas; in-flight after the 
end of the parabolic maneuvers (T4); and 24 h later (T5)]. 
 For the long-duration missions on the ISS, the pre-
flight measurements were taken during a period of 30 to 7 
days before the launch of the mission. In-flight samples 
were collected after 3 – 4 months and after almost 
6 months before return to Earth. Postflight measurements 
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were carried out on days 1 and 7. These time points were 
chosen with regard to the changes following adaptation to 
microgravity and reexposure to gravitation. 
 The intensity of self-perceived stress was quanti-
fied using a short and well-validated instrument, the KAB 
stress symptom questionnaire (German: Kurzfragebogen 
zur akutellen Beanspruchung; Mueller and Basler, 1993), 
which was completed at each indicated time point in com-
bination with the saliva and blood collections. The KAB is 
able to repeatedly determine an individuals ’ psychological 
state under the conditions of acute or chronic stress and is 
highly sensitive to short-term or situational changes during 
a stressful experience (Chouker et al., 2010). It consists of six 
matched bipolar adjectives describing the states of stress or 
relaxation (e.g.,  ‘ worried-happy ’ and  ‘ comfortable-uneasy ’ ). 
The rating is done on a 6-point Lickert scale, which ranges 
between 1 and 6 for all six matched adjectives. Higher KAB 
values indicate increased perceived stress levels. 
 Results of stress and EC 
measurements 
 Parabolic flight experiments 
 One of the aims of the PFC experiments was to charac-
terize the effects of kinetic stress on the response of the 
peripheral ECS and to relate the responsiveness of the 
system to stress-related outcomes of the experiment. 
Twenty-one volunteers participated in the PFC. Seven of 
these individuals reacted with a severe stress reaction 
accompanied by pronounced symptoms of motion sick-
ness, whereas the remaining 14 participants tolerated 
the experiment well and were in a low-stress condition 
without evidence of kinetosis (see  Table    1 for a compari-
son of the KAB scores). Interestingly, stress-intolerant 
individuals with acute motion sickness showed an absent 
EC response to kinetic stress and a massive activation of 
the HPA axis, whereas stress-tolerant participants showed 
the opposite pattern with a significant increase in plasma 
ECs and nearly unchanged plasma cortisol concentrations 
(Chouker et al., 2010;  Figure   1 ). 
 Furthermore, both groups showed different baseline 
levels of the ECs and nearly equivalent levels of cortisol 
before the parabolas. The group identified further as 
 ‘ highly stressed ’ showed already low activation of the ECS 
before the kinetic stress in contrast to the  ‘ low stressed ’ 
subjects who had higher initial concentrations of ECs. 
 Long-term space mission 
 During the long-term ISS missions, cosmonauts reported 
increased KAB stress levels during their stay on the ISS 
with maximal scores at the 6-month time point. The 
increase of stress scores was, at that number of investi-
gated subjects, however, not yet statistically significant 
( Figure   2 ). KAB scores paralleled the upsurge in EC blood 
concentration seen at the 6-month time point ( Figure    3 ) 
and the increase of free cortisol in saliva ( Table   2 ). In con-
trast to the acute stress model of PFC, the chronic stress 
exposure during long-duration missions demonstrates a 
positive relationship between stress, the ECS response, 
and the HPA axis activation. With the exception of the 
increase in whole-blood anandamide concentrations, the 
observed changes in 2-AG, saliva cortisol, and KAB stress 
scores were not statistically significant, so these observa-
tions need to be interpreted with caution. 
 Discussion and conclusions 
 The responsiveness of the EC system in humans to 
acute stress has been demonstrated in several recent 
studies (Hill et al., 2009; Dlugos et al., 2012). The exposure 
Score In-flight before 
parabolas (T0)
After 10 
parabolas (T1)
After 20 
parabolas (T2)
After 30 
parabolas (T3)
In-flight after 
parabolas (T4)
Motion sickness Motion sickness Motion sickness Motion sickness Motion sickness
Yes No Yes No Yes No Yes No Yes No
KAB stress 
score
2.4 ± 1.2 2.3 ± 0.9 3.4 ± 1.4a 2.1 ± 0.7 4.1 ± 1.3a 1.9 ± 0.6 3.7 ± 1.2a 1.5 ± 0.5 2.8 ± 1.1a 1.7 ± 0.7
 Table   1   Comparison of KAB stress symptom scores between high and low stressed participants with and without motion sickness during 
the parabolic flight experiment. 
 Data are mean  ±  SEM. Adapted from Chouker et al. (2010). 
 a p  < 0.01 compared with participants without motion sickness. 
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of healthy volunteers to kinetic stress during our 
parabolic flight experiments resulted in a significant 
increase in plasma EC concentrations in stress-tolerant 
participants, whereas highly stressed individuals with 
acute motion sickness showed an absent EC response 
and a massive activation of the HPA axis (Chouker et 
al., 2010). Recent animal experiments have confirmed 
the antinausea and antiemetic effects of cannabinoids 
and their receptors (Van Sickle et al., 2003; Parker et al., 
2009). Cannabinoids are also used to treat chemother-
apy-induced emesis in cancer patients (Machado Rocha 
et al., 2008). 
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 Figure   1  Comparison of salivary cortisol levels and blood concentra-
tions of the EC 2-AG in volunteers with and without motion sickness 
undergoing a parabolic flight experiment. 
 (A) Inverse relationship between blood concentrations of the EC 
2-AG and saliva cortisol in participants reporting low-stress condi-
tions without evidence of motion sickness. The increase in 2-AG 
during the parabolic maneuvers was associated with low saliva 
cortisol concentrations. *Significantly higher 2-AG concentrations in 
volunteers experiencing low-stress conditions. Data are expressed 
as mean  ±  SEM. (B) Opposite association between 2-AG concentra-
tions and saliva cortisol in highly stressed volunteers with motion 
sickness. These individuals had low blood 2-AG levels and very high 
saliva cortisol values. #Significantly higher saliva cortisol concen-
trations in highly stressed participants ( p  < 0.01,  t -test). Data are 
expressed as mean  ±  SEM. Adapted from Chouker et al. (2010). 
 Physical stress in trained and physically fit individu-
als induced by hard exercise during mountaineering or 
cycling also resulted in elevated EC concentrations, which 
returned to baseline after the termination of the stressful 
activity (Feuerecker et al., 2012; Heyman et al., 2012). Like-
wise, stress induced by the Trier Social Stress Test, a type 
of pure emotional stress without any physical challenge, is 
associated with a significant increase in 2-AG plasma levels 
with a baseline return during the recovery phase (Hill et al., 
2009). These findings suggest that an increased EC signal-
ing during acute stress is a protective response to maintain 
homeostasis and to enhance the recovery process. EC sig-
naling is also known to maintain HPA axis homeostasis by 
buffering basal activity as well as by mediating glucocor-
ticoid-induced fast feedback mechanisms, which repre-
sents the most important mechanism of the organism for 
stress adaptation and termination of the stress response 
(Evanson et al., 2010; Riebe and Wotjak, 2011). 
 Our small study in cosmonauts during a long-term 
mission onboard the ISS resulted in a comparable obser-
vation by demonstrating a more chronic activation of the 
ECS, probably the result of persistent and highly complex 
stressors acting on the crew. Although increased EC sig-
naling under acute or chronic conditions of stress might 
be beneficial for the organism in terms of stress tolerance, 
there is evidence of elevated plasma levels of anandamide 
and 2-AG in patients with atherosclerosis and coronary 
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 Figure   2  Changes in KAB stress symptom scores during long-dura-
tion missions on the ISS. 
 The increase in stress score is an indicator for psychological stress 
during the in-flight period in space (ISS). Preflight samples were 
taken in the first month before launch to the ISS, whereas the 
following time points were collected on the ISS after 3 – 4 and 6 
months of stay in space. Upon return, collections were performed 
after the first and seventh days, respectively (R+1 and R+7). Data 
are expressed as mean  ±  SEM. 
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artery disease (Sugamura et al., 2009; Weis et al., 2010a), 
whereas an inhibition in EC signaling by CB1 receptor 
blockade in circulating macrophages is associated with 
a significant reduction in proinflammatory mediators 
(Sugamura et al., 2009) as activated macrophages, and 
other nuclear blood cells are believed to be the major 
source of circulating ECs in the blood (Vogeser et al., 2006; 
Centonze et al., 2008). Therefore, an activated periph-
eral EC system might play a causal role in the reported 
increased risk for coronary artery disease and the asso-
ciated enhanced mortality in chronically stressed indi-
viduals, such as patients with posttraumatic stress dis-
order (Boscarino, 2008). These observations in humans 
illustrate the complex immunoregulatory functions of 
the ECS as mediated through the binding to the CB1 but 
also to the CB2 receptors as expressed on immune cells. 
The EC ligands are involved not only in the suppression 
of immune cell activation but also in the inhibition of pro-
inflammatory cytokine production and the modulation of 
T-cell functions. CB2 receptors, for instance, modulate the 
A
na
nd
am
id
e 
(n
g/
m
l)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
2-
A
ra
ch
id
on
oy
lg
ly
ce
ro
l (
2-
A
G
, n
g/
m
l) 
0
5
10
15
20
25
30
Anandamide (n=5)
2-Arachidonolyglycerol (2-AG, n=4)
Baseline ISS 3-
4 months
ISS 6
months
R+1 R+7
*
 Figure   3  Whole-blood EC concentrations during long-duration 
space missions on the ISS. 
 Blood anandamide levels increased significantly under in-flight 
conditions after 6 months on the ISS (n = 4 – 5; * p  < 0.05 vs. baseline 
for the EC anandamide). The increase in 2-AG blood concentrations 
appeared earlier but was not statistically significant. For the defini-
tion of time points, see Figure   2. Data are expressed as mean  ±  SEM. 
Preflight SEM ISS 3–4 M SEM ISS 6 M SEM R+1 SEM R+7 SEM
Cortisol 0.53 0.3 1.01 0.73 0.74 0.23 0.77 0.41 0.57 0.2
2-AG 6.1 1.9 11.9 6.63 9 2.07 3.5 0.81 4.6 2.3
 Table   2   Comparison of free cortisol concentrations in salivary samples and blood concentration of the EC 2-AG during long-duration 
missions on the ISS (see also Figure   3). 
 For the definition of time points, see  Figure   2 . Data are expressed as mean  ±  SEM. 
 ISS 3 – 4 M, in-flight samples collected after 3 – 4 months; ISS 6 M, in-flight samples collected after 6 months before return to Earth; R+1, 
postflight measurements carried out on day 1; R+7, postflight measurements carried out on day 7. 
antigen presentation properties of macrophages as well 
as their migration, phagocytosis, and adhesion character-
istics (Pandey et al., 2009). Conversely, the EC receptors 
are themselves also regulated through cell activation by 
humoral factors, which modulate their expression. Fur-
thermore, the lymphocyte TH1/TH2 ratio is influenced by 
ECs through CB2 receptors (Klein et al., 2003). 
 With regard to those multiple interactions of the ECS 
with variable immune functions, one could hypothesize 
that the increased activity of the EC system in chronically 
stressed individuals as observed in space might have long-
term adverse consequences. In acute stress situations, 
however, an appropriate ECS response seems to help main-
taining organ homeostasis. One might further conclude 
that EC baseline concentrations measured before defined 
stress situations could give a hint of the individuals ’ stress 
resistance during spaceflight conditions and thus might 
represent an indicator to detect stress-sensitive individuals 
for which special countermeasures could then be provided. 
 These assumptions need, however, experimental and 
clinical confirmation and may also be of great importance 
during long-term space missions. However, despite all 
efforts taken, challenged by methodological problems, low 
case numbers, and download limitations, the cause-effect 
relations (e.g., of the ECS activation) are far from being 
understood, as their attribution to one or more defined 
stressors during space voyage, such as confinement and 
weightlessness, can barely be separated during a mission. 
In this respect, however, a full and differential view on the 
causes and effects of the ECS activation can only be sys-
tematically achieved in Earth-bound studies, where indi-
viduals are subjected not to the entire range of stressors 
as on the ISS but separately to each of them or to their 
combinations. For instance, (i) confinement conditions on 
Earth as mimicked (e.g., in the MARS500 isolation study 
or during overwintering in Antarctica) allow to investigate 
the consequences of isolation and confinement without 
weightlessness. In contrast, (ii) continuous bed rest under 
conditions of a 6 ° head down tilt for up to 120 days are imi-
tating microgravity effects (Chouker et al., 2001). 
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 In summary, the presented studies using spaceflight 
conditions provide a first and likely important piece to 
unveil the role of the ECS in humans under extreme envi-
ronmental challenges. As the studies have been carried 
out under fully standardized conditions, maintaining the 
cooling chain for the frozen samples, the results demon-
strate that stress and EC research in space is possible. 
Moreover, the differential changes can provide meaning-
ful information for (planning) future space missions but 
also seem to be of benefit for humans on Earth (e.g., for 
kinetosis research). Further investigations on the role of 
the ECS and also the interactions with other organ func-
tions are warranted. 
 Materials and methods 
 Participants and technical accomplishment 
 Parabolic fl ights were performed with a modifi ed Airbus A300 that 
has been certifi ed to fl y specifi c fl ight maneuvers, producing 22 s peri-
ods of near weightlessness (close to  ‘ 0 g ’ ). For each parabola, an ini-
tial pullup occurred (~45 ° slope) inducing 1.8 g for about 20 s, before 
reaching  ‘ 0 g ’ conditions and 1.8 g again in the pullout phase. A typi-
cal fl ight day included 30 subsequently fl own parabolic maneuvers 
(http://www.novespace.com). Aft er an approval by the local Ethics 
Committee, signed informed consent, fl ight medical approval, and 
on-site clinical check of health status, 21 males (41.0  ±  1.5 years old) 
were included in the three PFCs accomplished between May 2006 
and September 2007. Samples were taken before, during, and aft er 
the parabolic fl ight as indicated. 
 The long-duration missions were performed by fi ve healthy 
male individuals (55.0  ±  3.8 years old) who each stayed on the ISS for 
6 months over a period of 2 years. 
 Figure   4  Expedition 13 crewmember with the ESA astronaut Thomas 
Reiter (left); Expedition 13 flight engineer; cosmonaut Pavel V. 
Vinogradov, ISS Commander representing Russia ’ s Federal Space 
Agency; and Jeff Williams, NASA space station science officer and 
flight engineer, pose for a photo onboard of the ISS (credit to ESA). 
 Figure   5  Expedition 13 crewmember Jeff Williams, Expedition 13 
NASA space station science officer and flight engineer, inserts a 
sample, such as the EC samples, in the -80 ° C laboratory freezer for 
ISS (MELFI) in the Destiny laboratory of the ISS. 
 MELFI is a low-temperature freezer facility with nominal operating 
temperatures of -80 ° C, -26 ° C, and +4 ° C that will preserve experi-
ment materials over long periods (credit to ESA). 
 Blood sampling, sampling preparation in 
space, and download of samples to Earth 
 During the long-duration missions, the data collected in-fl ight and 
postfl ight were compared with the data gained at the baseline data 
collection time point approximately 1 month before fl ight. The ground-
based work has mostly been conducted in Moscow and at the German 
Space Agency (DLR) site in Cologne. Additionally, return sample anal-
ysis was performed at the National Aeronautics and Space Adminis-
tration (NASA)-Johnsons Space Center (Houston, TX). On-orbit work 
for this protocol included two in-fl ight sample collections by the crew 
( Figure    4 ): in the mid-period of fl ight as well as aft er the maximum 
stay (6 months) before return. Sample preparation on the ISS was nec-
essary to ensure a reliable and adequate storage to best prepare for 
a further analysis on Earth. This included, aft er aseptic blood draw, 
centrifugation and storage procedures ( Figure   5 ). The KAB question-
naire was performed on a hard copy and fi lled in with a pencil. 
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